Vivos (RDGL) Free Cash Flow (2010 - 2025)
Vivos' (RDGL) quarterly Free Cash Flow came in at -$539554.0 in Q4 2025, down 14.58% year-on-year from -$631621.7 in Q4 2024, and down 17.68% quarter-over-quarter from -$458481.0 in Q3 2025.
Vivos (RDGL) Free Cash Flow (2010 - 2025) Analysis & Trends
Vivos has disclosed Free Cash Flow across 16 years of filings, most recently posting -$539554.0 for Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$539554.0, down 14.58% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.1 million (down 22.19% YoY), and the FY2025 annual result was -$2.2 million, down 28.32% from the prior year.
- Free Cash Flow came in at -$539554.0 for Q4 2025 at Vivos, down from -$458481.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$171119.0 in Q2 2022 to a low of -$604510.0 in Q2 2025.
- The 5-year median for Free Cash Flow is -$349317.0 (2021), against an average of -$355934.1.
- Across the five-year window, Free Cash Flow plunged 132.78% in 2021 and jumped 50.71% in 2022, its largest moves.
- Vivos' Free Cash Flow stood at -$235468.0 in 2021, then fell by 19.62% to -$281667.0 in 2022, then slumped by 64.43% to -$463137.0 in 2023, then fell by 1.68% to -$470912.0 in 2024, then slipped by 14.58% to -$539554.0 in 2025.
- The last three Free Cash Flow figures came in at -$539554.0 (Q4 2025), -$458481.0 (Q3 2025), and -$604510.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Vivos | - | - | -3,105.00 | -539,554.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -539,554.00 |
| Dec 31, 2025 | -539,554.00 |
| Sep 30, 2025 | -458,481.00 |
| Sep 30, 2025 | -458,481.00 |
| Jun 30, 2025 | -604,510.00 |
| Jun 30, 2025 | -604,510.00 |
| Mar 31, 2025 | -455,198.00 |
| Mar 31, 2025 | -455,198.00 |
| Dec 31, 2024 | -470,912.00 |
| Dec 31, 2024 | -470,912.00 |
| Sep 30, 2024 | -506,257.00 |
| Sep 30, 2024 | -506,257.00 |
| Jun 30, 2024 | -355,412.00 |
| Jun 30, 2024 | -355,412.00 |
| Mar 31, 2024 | -351,458.00 |
| Mar 31, 2024 | -351,458.00 |
| Dec 31, 2023 | -463,137.00 |
| Dec 31, 2023 | -463,137.00 |
| Sep 30, 2023 | -221,923.00 |
| Sep 30, 2023 | -221,923.00 |